AOD-9604
£23.49
AOD-9604 is the 16-amino-acid disulphide-cyclised Tyr-hGH(177-191) fragment, supplied as above 99% HPLC-verified research material. For laboratory, analytical and scientific research only. Not for human or veterinary use.
VERIFY COA / THIRD-PARTY TEST RESULT
Each AOD-9604 5mg batch is supported by an independent third-party analytical report.
- Batch reference
- ZC0024
- LC-MS/MS purity
- 99.447%
- Net peptide content
- 5.31 mg
- Testing laboratory
- Sonic Laboratories
- Laboratory reference
- SD20260829_013_AOD5
Use the batch number printed on the product label to confirm the report for your supplied batch.
Description
For Research Use Only. This product is supplied exclusively for laboratory research and is not intended for human or veterinary use.
AOD-9604 Research Peptide
AOD-9604 is a 16-amino-acid peptide described as Tyr-hGH(177-191): the C-terminal hGH 177-191 region with an added N-terminal tyrosine. Its two cysteine residues form an intramolecular disulphide bond.
The compound has been investigated in metabolic, receptor and tissue-model research. Early animal findings did not translate into an approved obesity medicine, so the page distinguishes preclinical observations from established human outcomes.
Technical Specifications
| Product | AOD-9604 |
|---|---|
| Peptide length | 16 amino acids |
| Identity | Tyr-hGH(177-191) |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-PheYLRIVQCRSVEGSCGF |
| Structural feature | Intramolecular disulphide bond between the two cysteine residues |
| Molecular weight | Approximately 1815 g/mol |
| Purity | Above 99% by third-party HPLC testing |
| Physical form | Lyophilised research material |
| Available format | 5mg |
| Intended use | Laboratory research and analytical use only |
Independent Batch Testing
Every current ZENTRA AOD-9604 batch is independently tested and records an HPLC purity result above 99%. Use the batch number printed on the product label to locate the corresponding third-party report in our Batch Verification and COA Centre. Researchers should consult the individual report for the exact analytical methods, result and testing date for their supplied batch.
AOD-9604 Research Context
Published rodent studies examined metabolic effects of the C-terminal hGH fragment. Later work, including studies under the name LAT8881, investigated mechanisms outside the full growth-hormone receptor pathway and additional cell or tissue responses.
AOD-9604 should not be described as proven to produce weight loss or cartilage repair in people. ZENTRA supplies it solely as a preclinical research reagent.
Storage and Handling
Keep unopened lyophilised material at approximately -20°C for long-term storage or 2-8°C for short-term laboratory storage. Protect from light, moisture and repeated temperature changes.
AOD-9604 Research FAQs
What is AOD-9604?
It is the Tyr-hGH(177-191) peptide: the hGH 177-191 region with an additional N-terminal tyrosine.
How many amino acids does it contain?
AOD-9604 contains 16 amino acids.
Is it the same as full growth hormone?
No. It is a short C-terminal fragment and does not reproduce the complete structure or pharmacology of hGH.
What has been researched?
Studies have examined metabolic pathways and, more recently, other cell and tissue models. Much of the evidence is preclinical.
How is purity verified?
The current batch is independently HPLC tested above 99% and linked to its online COA.
Is it intended for weight-loss or human use?
No. It is supplied strictly for laboratory research and not as a treatment.
Selected Scientific Sources
- Metabolic studies of the synthetic lipolytic domain AOD9604.
- Effects of hGH and AOD9604 in obese mice.
- Research involving LAT8881, formerly AOD9604.
Research Resources
- Tesamorelin Research Peptide
- MOTS-c Research Peptide
- Batch Verification and COAs
- Research Compound Storage Guide
- Browse All Research Peptides
For research use only. Not for human or veterinary use.
Additional information
| Size | 5mg |
|---|





Reviews
There are no reviews yet.